“Baby Cleaning Products Market Report is set to have rapid growth due to increasing birth rate, constant launch of new product baby care lines and innovative marketing strategies adopted by major players at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report

04 September 2019
Pharma

Visiongain has launched a new pharma report Baby Cleaning Products Market: By Product (Cleaning Wipes, Bottle Wash, Laundry Detergents), By Sales Channel (Retail, Non-Retail, E-Commerce), Regional and Segment Forecasts

The global Baby Cleaning Products market is poised for rapid growth between 2019 and 2029. Increasing consciousness about baby hygiene and numerous initiatives being undertaken to encourage the same are among the main development stimulants for the baby cleaning products market.

The growing awareness of child hygiene and the various initiatives undertaken to promote the same are among the main stimulants of growth for the market. For example, in October 2018, the United Nations International Children's Emergency Fund (UNICEF) in collaboration with BBC Media Action funded a project called Baby WASH in Zequalla and Sekota Woredas in northern Ethiopia.

The main reason for this project was to reduce microbial contamination in children and newborns. Such initiatives are planned to encourage parents to use baby cleaning products, such as baby washings, baby wipes and laundry detergents, and fabric balms instead of regular products to prevent contamination. This, in turn, will stimulate market growth.

Leading companies featured in the report include Johnson & Johnson Services, Inc.; Koninklijke Philips N.V.; Pigeon Corporation; Nuby; Mayborn Group Limited; Kimberly-Clark; and Procter & Gamble.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

Read

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

Read

Visiongain Publishes Aptamer Technologies Market Report 2021-2031

Over the last few years, the aptamers has gained widespread attention due to the technological advancements and growth in understanding of the oligonucleotide therapeutics that inhabit the human body.

29 April 2021

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031

Rising prevalence of inflammatory bowel disease including Crohn’s disease and ulcerative colitis; raising awareness for IBD in developing countries; escalating investment in drug R&D by pharmaceutical companies; new product launches worldwide, growing chronic diseases healthcare awareness are some of the major factors that boosting the growth of global IBD drugs market.

29 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever